Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Heparin doses and major bleedings.

Literature DB >> 2872423

Heparin doses and major bleedings.

A Morabia.

Abstract

Entities: Chemical

Mesh：

Substances：
Heparin

Year: 1986 PMID： 2872423 DOI： 10.1016/s0140-6736(86)91421-2

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Description and Evaluation of the Implementation of a Weight-Based, Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center.

Authors: James W Schurr; Craig A Stevens; Anne Bane; Carol Luppi; Sarah E Culbreth; Amy Leigh Miller; Jean M Connors; Katelyn W Sylvester
Journal: Clin Appl Thromb Hemost Date: 2017-08-04 Impact factor: 2.389

2. Issues Regarding the Use of Heparin Following Streptokinase Therapy.

Authors:
Journal: J Thromb Thrombolysis Date: 1995 Impact factor: 2.300

Review 3. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors: David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal: Chest Date: 2012-02 Impact factor: 9.410

4. A less-intensive anticoagulation protocol of therapeutic unfractionated heparin administration for pregnant patients.

Authors: Reiko Neki; Mana Mitsuguro; Akira Okamoto; Kazufumi Ida; Takekazu Miyoshi; Chizuko Kamiya; Naoko Iwanaga; Toshiyuki Miyata; Jun Yoshimatsu
Journal: Int J Hematol Date: 2019-07-25 Impact factor: 2.490

5. Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

Authors: G F Handeland; U Abildgaard; H A Holm; K E Arnesen
Journal: Eur J Clin Pharmacol Date: 1990 Impact factor: 2.953

Review 6. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations.

Authors: Sebastian Harder; Ute Klinkhardt; John M Alvarez
Journal: Clin Pharmacokinet Date: 2004 Impact factor: 6.447

Heparin doses and major bleedings.

1. Description and Evaluation of the Implementation of a Weight-Based, Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center.

2. Issues Regarding the Use of Heparin Following Streptokinase Therapy.

Review 3. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

4. A less-intensive anticoagulation protocol of therapeutic unfractionated heparin administration for pregnant patients.

5. Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

Review 6. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations.

7. Effects of factor VIII levels on the APTT and anti-Xa activity under a therapeutic dose of heparin.

8. Evaluation of initial heparin infusion rates for a high-dose protocol.

9. Efficacy and risks of anticoagulation for cerebral venous thrombosis.

Review 10. Pharmacologic prophylaxis of portal venous system thrombosis after splenectomy: a meta-analysis.